Type of Study:

Interventional

Study Design:

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label

Outcome Measure:

Patients' knowledge about clinical trials measured by the questionnaire Quality of Informed Consent

Outcome Description:

The questionnaire is sent to patients within a week after consenting to the trial. One reminder is sent to those not responding within two weeks.

Outcome Time Frame:

The questionnaire is sent to patients within a week after consenting to the trial.

Safety Issue:

No

Principal Investigator

Mia Bergenmar, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Department of Oncology, Karolinska University Hospital and Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden

Authority:

Sweden: Regional Ethical Review Board

Study ID:

QuIC-3

NCT ID:

NCT01502254

Start Date:

October 2008

Completion Date:

March 2013

Related Keywords:

• Cancer
• Informed consent
• Cancer clinical trials
• Patient information
• Knowledge
• Questionnaire
• Patient Eligible for a Phase II or III Cancer Clinical Trial
• Scheduled Clinical Visit for Information About a Trial

Name	Location